This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Limin Liang: Innovator in mRNA Vaccine Development
Introduction
Limin Liang is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of vaccine development, particularly focusing on respiratory syncytial virus (RSV). His innovative work has the potential to impact public health positively.
Latest Patents
Limin Liang holds a patent for a "Respiratory Syncytial Virus mRNA Vaccine, and Preparation Method Therefor and Use Thereof." This patent represents a crucial advancement in the fight against RSV, which is a common cause of respiratory infections in infants and young children. He has 1 patent to his name, showcasing his dedication to innovation in the pharmaceutical industry.
Career Highlights
Limin Liang is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. This company is known for its commitment to developing cutting-edge medical solutions. His role at the company allows him to work on groundbreaking projects that aim to improve health outcomes.
Collaborations
Limin Liang collaborates with talented individuals such as Gengshen Song and Kai Dong. Their combined expertise fosters an environment of innovation and creativity, leading to advancements in vaccine technology.
Conclusion
Limin Liang's contributions to mRNA vaccine development highlight his role as a key inventor in the pharmaceutical field. His work not only advances scientific knowledge but also has the potential to save lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile